Back to UBS Group AG UBS Group AG

SNOASNOA
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in SONOMA PHARMACEUTICALS INC

Yes. Ubs holds 7,808 shares of SNOA (Sonoma Pharmaceuticals), worth $9,604, as of its Q2 2026 13F filing. It increased the position from 6 shares in Q1 2026. Ubs has held SNOA since Q3 2024, across 8 quarterly 13F filings.

Current Value

$9,604

Current Shares

7,808

Total Value Change

-$29,477

Total Shares Change

-4,922

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,808
+1300x
$9,6040.0%$1.23
19
2026-Q1
Unchanged
6
0.0%
$130.0%$2.13
0
2025-Q4
Decreased
6
-94.4%
$220.0%$3.64
0
2025-Q3
Decreased
108
-99.3%
$4190.0%$3.88
0
2025-Q2
Increased
14,417
+678.5%
$41,0160.0%$2.85
22
2025-Q1
Decreased
1,852
-89.4%
$4,0560.0%$2.19
0
2024-Q4
Increased
17,430
+36.9%
$46,8870.0%$2.69
18
2024-Q3
New
12,730
-
$39,0810.0%$3.07
31

Other major holders of SNOA: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used